Placebo effect in chronic inflammatory demyelinating polyneuropathy: The PATH study and a systematic review

The Polyneuropathy And Treatment with Hizentra (PATH) study required subjects with chronic inflammatory demyelinating polyneuropathy (CIDP) to show dependency on immunoglobulin G (IgG) and then be restabilized on IgG before being randomized to placebo or one of two doses of subcutaneous immunoglobul...

Descripción completa

Detalles Bibliográficos
Autores principales: Lewis, Richard A., Cornblath, David R., Hartung, Hans‐Peter, Sobue, Gens, Lawo, John‐Philip, Mielke, Orell, Durn, Billie L., Bril, Vera, Merkies, Ingemar S. J., Bassett, Paul, Cleasby, Alexa, van Schaik, Ivo N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Periodicals, Inc. 2020
Materias:
Research Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7497019/
https://www.ncbi.nlm.nih.gov/pubmed/32627277
http://dx.doi.org/10.1111/jns.12402

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7497019/
https://www.ncbi.nlm.nih.gov/pubmed/32627277
http://dx.doi.org/10.1111/jns.12402

Ejemplares similares